Aumet closes $12 million Series A led by Emkan Capital

Saudi Arabia-based healthtech company Aumet has raised $12 million in Series A funding led by Emkan Capital. The startup, which builds AI-powered procurement systems for healthcare providers, has already processed over $1 billion in transactions across its platform.

The funding round included participation from Qatar Development Bank, SABAH VC, and AAIC, alongside existing investors Shorooq Partners and Right Side Capital Management. Strategic healthcare investors Cigalah Group and Salehiya Trading Company also joined the round.

The money will be used for...

Aumet plans to use the new funding to:

  • Expand AI capabilities across its procurement platform
  • Scale enterprise deployments to more hospitals and healthcare systems
  • Grow operations across GCC markets and internationally
  • Further develop its three-tier product suite covering individual pharmacies to national healthcare systems

Why does it matter?

Healthcare supply chains in emerging markets face major inefficiencies that drive up costs and create shortages. Aumet's platform addresses this by using AI to automate procurement decisions and optimize inventory management across the entire healthcare ecosystem.

The company has already proven significant scale, connecting over 12,000 pharmacies across Jordan, Egypt, and Saudi Arabia with more than 1,000 pharmaceutical suppliers. Its enterprise solution is now deployed across 32 hospitals, 500+ medical centers, and 18+ medical warehouses in Jordan alone.

"Healthcare supply chains don't suffer from lack of supply — they suffer from lack of intelligence," said Yahya Aqel, CEO and co-founder of Aumet. "We are building the AI-first operating system that powers procurement decisions across the entire healthcare ecosystem."

The context

Founded in 2016 by Yahya Aqel, Adel Haddad, and Shahed Jaber, Aumet has evolved from a simple healthcare marketplace into a comprehensive AI-powered procurement operating system. The company previously raised $7 million in pre-Series A funding in March 2023.

Aumet operates three main product tiers:

  • Pulse: Cloud-based inventory and procurement system for individual pharmacies
  • Chain: Centralized procurement solution for pharmacy chains
  • Enterprise: AI-powered cognitive procurement OS for hospitals and national healthcare systems

The startup's enterprise solution was first deployed at Al-Basheer Hospital, Jordan's largest hospital, in collaboration with the country's Ministry of Health. It has since partnered with Presight, an Abu Dhabi-based AI company, to scale across public healthcare systems.

While companies like Clarium are tackling similar healthcare supply chain challenges in the United States, Aumet is positioned to address these issues specifically in emerging markets where healthcare systems are more fragmented and require localized solutions.

Funding 💰

Round $12M
Series A
Lead investor(s) Emkan Capital
Also participating Qatar Development Bank, SABAH VC, AAIC Investment, Shorooq Partners, Right Side Capital Management

About 🏢

Aumet has developed a B2B platform that supports healthcare providers with their business decisions and performance. Said platform facilitates data exchange between healthcare providers, manufacturers, and distributors to enable them to make the right decision. In other words, it digitizes paperwork and makes processes more efficient. Aumet operates in Saudi Arabia, Jordan, and Egypt. more
source

💡Did you know?

You can take your DHArab experience to the next level with our Premium Membership.
👉 Click here to learn more